Real‐world experience with risankizumab in patients with plaque psoriasis: a retrospective study

M. Mehta has no conflicts to disclose. A.O’Toole has been an investigator, speaker or advisory board member for AbbVie, Amgen, Arcutis, Boehringer Ingelheim, BMS, Celgene, Dermira, Galderma, GSK, Eli Lilly, Incyte, Janssen, Leo Pharma, Merck, Novartis, Pfizer, Regeneron, Sanofi Genzyme, Sun Pharma, UCB, Valeant/Bausch. M. Gooderham has been an investigator, speaker, consultant or advisory board member for AbbVie, Amgen, Akros, Arcutis, Boehringer Ingelheim, BMS, Celgene, Dermira, Dermavant, Galderma, GSK, Eli Lilly, Incyte, Janssen, Kyowa Kirin, Leo Pharma, Medimmune, Merck, Novartis, Pfizer, Regeneron, Sanofi Genzyme, Sun Pharma, UCB, Valeant/Bausch.